| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2008 | CN100411613C Fast releasing solid omeprazole prepn and its preparation process |
| 08/20/2008 | CN100411612C Quick-disintegration tablets of calcium atovastatine, and its preparation method |
| 08/20/2008 | CN100411611C Matrix for sustained, invariant and independent release of active compounds |
| 08/20/2008 | CN100411608C Method of preparing a formulation containing a microdosed active component |
| 08/19/2008 | US7415360 Multiparameter method of screening for atherosclerosis-related coronary heart disease or stroke |
| 08/19/2008 | US7414154 polyamine compound is administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy |
| 08/19/2008 | US7414152 N-substituted p-menthane carboxamides |
| 08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
| 08/19/2008 | US7414131 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 08/19/2008 | US7414128 Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate |
| 08/19/2008 | US7414127 7 α-Enedione-substituted steroid compounds |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections |
| 08/19/2008 | US7414114 Removing organic or inorganic solvent and water from solution comprising hydrated compound; increased stability |
| 08/19/2008 | US7414079 Alkyl alicyclic ethers, e.g., isopulegyl methyl ether, as a eucalptol replacement having a better flavor in oral care products for the mouth, throat and airways to produce a refreshing and clearing feelinga ; foods, tobacco product, candy, dentifrices; mouthwashes and pharmaceuticals |
| 08/19/2008 | US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants |
| 08/19/2008 | US7414077 Therapeutic intervention to mimic the effect of caloric restriction |
| 08/19/2008 | US7414076 Methods and compositions for treating amyloid-related diseases |
| 08/19/2008 | US7414075 capsinoid substance selected from the group consisting of 4-hydroxy-3-methoxybenzyl (E)-8-methyl-6-nonenoate and 4-hydroxy-3-methoxybenzyl 8-methylnonanoate; treating arthrosclerosis |
| 08/19/2008 | US7414074 Acetic acid 7-acetoxy-1-[1-(3,4-diacetoxy-4'-hydroxy-2'-oxo-6-sulfooxymethyl-3,4,5,6-tetrahydro-2.H.,2'.H.-[2,3']bipyranyl-6'-yl)-1-methyl-ethyl]-4,6,8,12,14,16-hexamethyl-octadeca-2,4,10,12-tetraenyl ester; antiinflammatory agent; psoriasis, atopic, eczematous, seborrheic dermatitis |
| 08/19/2008 | US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 08/19/2008 | US7414072 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414070 Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions |
| 08/19/2008 | US7414069 Antituberculosis compounds, Hirsutellones A, B, and C |
| 08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414066 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | US7414064 Pesticides for crops; agriculture, horticulture |
| 08/19/2008 | US7414063 e.g. 2-(2-bromo-4-fluoro-phenoxy)-ethyl]-[2-(isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester; serine/threonine kinase inhibitor; anticarcinogenic agent; solid tumor, leukemia |
| 08/19/2008 | US7414062 such as 5-[8-(3-dimethylcarbamoyl-3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-pentanoic acid; non-opioid analgesic; side effect reduction; for stimulating opioid receptors |
| 08/19/2008 | US7414061 Aryl-isoxazol-4-yl-imidazole derivatives |
| 08/19/2008 | US7414060 Pyridine-2-carboxyamide derivatives |
| 08/19/2008 | US7414059 Pyrazolyl and imidazolyl pyrimidines as CRF antagonists |
| 08/19/2008 | US7414058 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 08/19/2008 | US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414055 Inhibitors of Akt activity |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 08/19/2008 | US7414052 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 08/19/2008 | US7414051 8-(4-Methylpiperazin-1-yl)-6-(1-naphthylsulfonyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]-indazole; antidepressant, anxiolytic agent, cognition activator; |
| 08/19/2008 | US7414050 e.g. 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 08/19/2008 | US7414049 gamma -secretase inhibitors; treating Alzheimer's disease by blocking the activity of gamma -secretase and reducing or preventing the formation of the various amyloidogenic Abeta peptides; good thermodynamic solubility and bioavailability |
| 08/19/2008 | US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | US7414045 Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors |
| 08/19/2008 | US7414044 peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide; dye containing a chelated metal, such as hematoporphyrin; aromatic redox compound, such as benzoquinone |
| 08/19/2008 | US7414043 9-α-substituted estratrienes as selectively active estrogens |
| 08/19/2008 | US7414042 Topically applying betulinic acid or a betulinic acid derivative to tumor site |
| 08/19/2008 | US7414041 Reducing tetracycline resistance in living cells |
| 08/19/2008 | US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
| 08/19/2008 | US7414039 Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| 08/19/2008 | US7414038 embolizing agent for arteriovenous aneurysm, which comprises the embolizing material and an appropriate physiologically acceptable water-soluble organic acid |
| 08/19/2008 | US7414037 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea |
| 08/19/2008 | US7414036 Prevent tissue or organ damage; antiischemic agents |
| 08/19/2008 | US7414035 hKIS composition and methods of use |
| 08/19/2008 | US7414034 Administering antibody polynucleotide; controlling glutamate receptors |
| 08/19/2008 | US7414033 Modulation of diacylglycerol acyltransferase 1 expression |
| 08/19/2008 | US7414032 Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8+ CTL |
| 08/19/2008 | US7414031 5-nitro-nucleoside compounds for treating viral infections |
| 08/19/2008 | US7414030 Drugs comprising macromolecules, prodrugs and carriers mixtures administered for prophylaxis gramnegative bacterial infections; antibiotics |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | US7414021 Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
| 08/19/2008 | US7413896 Method for improving protein production |
| 08/19/2008 | US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents |
| 08/19/2008 | US7413881 Chitosan and method of preparing chitosan |
| 08/19/2008 | US7413751 Methods of treatment using a gastric retained losartan dosage |
| 08/19/2008 | US7413749 Adimistering analgesics by titration for dosage using tramadol and kits |
| 08/19/2008 | US7413748 comprises patches for improved dosage |
| 08/19/2008 | US7413747 Transdermal therapeutic system for treating Parkinsonism |
| 08/19/2008 | US7413738 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 08/19/2008 | US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 08/19/2008 | US7413538 Epitopes formed by non-covalent association of conjugates |
| 08/19/2008 | CA2621616A1 Topical gatifloxacin formulations |
| 08/19/2008 | CA2501543C Enhancement of alcohol metabolism |
| 08/19/2008 | CA2488422C Stable solid medicinal ramosetron composition for oral administration |
| 08/19/2008 | CA2468708C Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2434906C Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2396722C Formulations of active components in the form of a solid dispersion |
| 08/19/2008 | CA2390886C Use of fumaric acid derivatives for treating mitochondrial diseases |
| 08/19/2008 | CA2376803C Topical anti-microbial compositions |
| 08/19/2008 | CA2370003C A composition and method for the enhancement of the efficacy of drugs |
| 08/19/2008 | CA2369448C Medicament for inhibiting nf-kb |
| 08/19/2008 | CA2353943C Method of drying a lactulose solution |
| 08/19/2008 | CA2282682C Tazarotene and corticosteroid treatment for psoriasis |
| 08/19/2008 | CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2241469C Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
| 08/19/2008 | CA2219656C Antibacterial cephalosporins |
| 08/19/2008 | CA2207185C Carbostyril derivatives as antithrombotic agents |
| 08/19/2008 | CA2205134C A method for treating vascular headaches |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/15/2008 | CA2621575A1 Drug detoxification protocol using microdosing |